6869 — Sysmex Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Sysmex, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	305,073	363,780	410,502	461,510	508,643
Cost of Revenue
Gross Profit	154,303	190,585	216,083	242,497	271,978
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	255,153	296,490	336,884	383,180	421,060
Operating Profit	49,920	67,290	73,618	78,330	87,583
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	46,251	64,346	68,713	74,600	79,221
Provision for Income Taxes
Net Income After Taxes	31,866	44,072	45,725	49,774	53,576
Minority Interest
Net Income Before Extraordinary Items
Net Income	31,905	44,093	45,784	49,639	53,669
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31,905	44,093	45,784	49,639	53,669
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	50.8	72	73.3	81.1	89.6
Dividends per Share
Special Dividends per Share